
GC36773
Nrf2-IN-1
Also known as 1-[(4-tert-butylphenyl)methyl]-3-(4-chlorophenyl)-N-hydroxypyrazole-5-carboxamide
Nrf2-IN-1 is an inhibitor of nuclear factor-erythroid 2-related factor 2 (Nrf2)· Nrf2-IN-1 is developed for the research of acute myeloid leukemia (AML)
ChemicalCAS1610022-76-8MW383.87FormulaC21H22ClN3O2
- CAS number
- 1610022-76-8
- Molecular weight
- 383.87
- Formula
- C21H22ClN3O2
- Solubility
- DMSO: 260 mg/mL (677·31 mM)
- InChIKey
- ZFDMUUNGVLREEC-UHFFFAOYSA-N
- Catalogue number
- GC36773
- Brand
- GLPBIO
Computed properties PubChem CID 76900951 · XLogP 4.9 · TPSA 67.2 Ų · H-bond donors 2
- XLogP
- 4.9
- TPSA
- 67.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 5
- Heavy atoms
- 27
SMILES CC(C)(C)C1=CC=C(C=C1)CN2C(=CC(=N2)C3=CC=C(C=C3)Cl)C(=O)NO
Computed descriptors from PubChem (CID 76900951), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il